Anticancer Drugs
MONOCLONAL ANTIBODIES
Bevacizumab AVASTIN
Cetuximab ERBITUX
Daratumumab DARZALEX
Panitumumab VECTIBIX
Ramucirumab CYRAMZA
Rituximab RITUXAN
Trastuzumab HERCEPTIN
Bevacizumab AVASTIN
Cetuximab ERBITUX
Daratumumab DARZALEX
Panitumumab VECTIBIX
Ramucirumab CYRAMZA
Rituximab RITUXAN
Trastuzumab HERCEPTIN